Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
bioAffinity Technologies, Inc. - Common Stock
(NQ:
BIAF
)
1.620
-0.070 (-4.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
25,660
Open
1.650
Bid (Size)
1.560 (5)
Ask (Size)
1.680 (100)
Prev. Close
1.690
Today's Range
1.620 - 1.679
52wk Range
0.9548 - 3.620
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO
August 23, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q2 2024
August 14, 2024
bioAffinity Technologies just reported results for the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-4.14%
-4.14%
1 Month
-38.40%
-38.40%
3 Month
-36.22%
-36.22%
6 Month
-11.01%
-11.01%
1 Year
-7.43%
-7.43%
More News
Read More
bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales
August 14, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
August 05, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Crude Oil Falls Sharply; Exxon Mobil Earnings Top Views
August 02, 2024
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Tumbles 3%; US Economy Adds 114,000 Jobs In July
August 02, 2024
Via
Benzinga
Topics
Economy
Exposures
Economy
Dow Dips Over 400 Points; Apple Posts Upbeat Earnings
August 02, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million
August 02, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Biotricity and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 12, 2024
Via
ACCESSWIRE
bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung
July 09, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
BioVie and bioAffinity Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
July 05, 2024
Via
ACCESSWIRE
bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests
June 12, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q1 2024
May 15, 2024
Via
InvestorPlace
bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes
May 15, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies News Update
May 02, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
April 24, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
April 09, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
April 05, 2024
Via
Benzinga
BIAF Stock Earnings: bioAffinity Technologies Reported Results for Q4 2023
April 01, 2024
Via
InvestorPlace
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
April 01, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
March 11, 2024
Via
Benzinga
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 11, 2024
Via
Benzinga
Exposures
Product Safety
bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement
March 08, 2024
From
bioAffinity Technologies, Inc.
Via
Business Wire
Nasdaq Gains 100 Points; Campbell Soup Earnings Top Views
March 06, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 06, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
